951395-08-7

Tafamidis Meglumine

Commercial active pharmaceutical ingredient for transthyretin amyloidosis.

Product overview

CAS RN:

951395-08-7

Therapeutic area:

Transthyretin amyloidosis

API category:

Transthyretin (TTR) stabilizer

Manufacturing site:

CZECH-GEN, a.s., Czech Republic

Product status:

Commercial API

Regulatory status

CEP:

Not available

ASMF:

Available

US DMF:

Not available

Other markets supported:

Not available

Supply information

Typical commercial batch size:

5–15 kg

Minimum order quantity:

Not established

Sample availability:

Available upon request

Standard lead time:

2–3 weeks when the material is in stock

Available documentation

GMP certificate:

Download here

Residual solvents statement:

Available upon request

Change notification policy:

Available upon request

Get in touch

Contact

Interested in a partnership, career opportunity or media information? Contact us and we will connect you with the right person.

By submitting, you agree to our personal data retention policy.

Thank you! Your submission has been received!
Something went wrong while submitting the form.

Related products

Start a business partnership

Looking for a partner for development and manufacturing?

Contact us to discuss active pharmaceutical ingredients, CDMO services or specialty chemicals.

Discuss a partnership